retatrutide ly3437943 glp-1 gip glucagon Retatrutide—A Game Changer in Obesity Pharmacotherapy LY3437943, a novel triple glucagon,
Description
Weight Loss Support Semaglutide has shown promising results in aiding weight loss
You're training to preserve
Lowers Blood Pressure High blood pressure is a major risk factor for kidney disease
Vomiting and diarrhea often occur during the first few weeks, particularly after dose increases
The exposure curve is still climbing
Retatrutide is currently being studied as a once-weekly subcutaneous injection, a route that allows the drug to be absorbed gradually and reliably into systemic circulation
